Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Volume matters in the systemic treatment of metastatic pancreatic cancer: a population-based study in the Netherlands
Authors
Keywords
Pancreatic cancer, High-volume hospital, Palliative chemotherapy, Survival, Population based
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 142, Issue 6, Pages 1353-1360
Publisher
Springer Nature
Online
2016-03-19
DOI
10.1007/s00432-016-2140-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Malignant Biliary Tract Obstruction: Evaluation and Therapy
- (2017) David Chu et al. Journal of the National Comprehensive Cancer Network
- Impact of care at comprehensive cancer centers on outcome: Results from a population-based study
- (2015) Julie A. Wolfson et al. CANCER
- Prospective evaluation of ERCP performance: results of a nationwide quality registry
- (2015) Vivian Ekkelenkamp et al. ENDOSCOPY
- nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
- (2015) D. Goldstein et al. JNCI-Journal of the National Cancer Institute
- Describing Patterns of Care in Pancreatic Cancer
- (2015) Elizabeth A. Burmeister et al. PANCREAS
- nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
- (2015) D. Goldstein et al. JNCI-Journal of the National Cancer Institute
- Ten weeks to live: A population-based study on treatment and survival of patients with metastatic pancreatic cancer in the south of the Netherlands
- (2014) Nienke Bernards et al. ACTA ONCOLOGICA
- Impact of centralization of pancreatic cancer surgery on resection rates and survival
- (2014) G. A. Gooiker et al. BRITISH JOURNAL OF SURGERY
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Therapy Preferences in Melanoma Treatment - Willingness to Pay and Preference of Quality versus Length of Life of Patients, Physicians and Healthy Controls
- (2014) Ramona Krammer et al. PLoS One
- Uptake and Patterns of Use of Gemcitabine for Metastatic Pancreatic Cancer: A Population-Based Study
- (2013) Paul E. Oberstein et al. CANCER INVESTIGATION
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- "Well, I Think There Is Great Variation...": A Qualitative Study of Oncologists' Experiences and Views Regarding Medical Criteria and Other Factors Relevant to Treatment Decisions in Advanced Cancer
- (2013) J. Schildmann et al. ONCOLOGIST
- Modest Improvement in Overall Survival for Patients With Metastatic Pancreatic Cancer
- (2013) Mathias Worni et al. PANCREAS
- Centralization of Highly Complex Low-Volume Procedures in Upper Gastrointestinal Surgery. A Summary of Systematic Reviews and Meta-Analyses
- (2012) Johanna A.M.G. Tol et al. DIGESTIVE SURGERY
- Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery
- (2011) G. A. Gooiker et al. BRITISH JOURNAL OF SURGERY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of chemotherapy at end of life in oncology patients
- (2009) S. Kao et al. ANNALS OF ONCOLOGY
- Management and prognosis of pancreatic cancer over a 30-year period
- (2009) M David et al. BRITISH JOURNAL OF CANCER
- Is there under-treatment of pancreatic cancer? Evidence from a population-based study in Ireland
- (2009) L. Sharp et al. EUROPEAN JOURNAL OF CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started